human neutrophil peptide 3

was SY to defensins until 2001

Also Known As:

DEFA3 protein, human; HNP-3; HNP3 protein, human; HP-3 peptide; alpha-defensin 3, human

Networked: 4 relevant articles (1 outcomes, 1 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Amino Acids, Peptides, and Proteins: 1
- Proteins: 484843
  - Membrane Proteins: 10078
    - Pore Forming Cytotoxic Proteins
      - Antimicrobial Cationic Peptides: 414
        Defensins: 1422
        alpha-Defensins: 313
        human neutrophil peptide 3: 4
- Peptides: 82426
  - Antimicrobial Peptides: 3727
    - Antimicrobial Cationic Peptides: 414
      - Defensins: 1422
        alpha-Defensins: 313
        human neutrophil peptide 3: 4
  - Antimicrobial Cationic Peptides: 414
    - Defensins: 1422
      - alpha-Defensins: 313
        human neutrophil peptide 3: 4

Experts

1.	Gursoy, Ulvi K: 1 article (01/2013)
2.	Könönen, Eija: 1 article (01/2013)
3.	Luukkonen, Noora: 1 article (01/2013)
4.	Uitto, Veli-Jukka: 1 article (01/2013)
5.	Hashimoto, Shinichi: 1 article (04/2012)
6.	Ibusuki, Kazunari: 1 article (04/2012)
7.	Ibusuki, Rie: 1 article (04/2012)
8.	Ido, Akio: 1 article (04/2012)
9.	Iwashita, Yuji: 1 article (04/2012)
10.	Kanmura, Shuji: 1 article (04/2012)

Related Diseases

1.	Ulcerative Colitis 04/01/2012 - "Human neutrophil peptide (HNP)-1, HNP-2, and HNP-3 (HNP-1-3) are useful biomarkers for ulcerative colitis (UC). " 01/15/2009 - "In addition, these peptides are involved in CD8+ T cell response to HIV-1, increased pulmonary infection risk among cystic fibrosis patients, upregulated levels of HNP-5 for patients with ulcerative colitis and Crohn's disease, and monitoring HNP-3 levels as a tumor classification scheme for cutaneous T cell lymphomas, and have promise in the pharmaceutical field as a new class of antibiotics. "
2.	Cutaneous T-Cell Lymphoma (Lymphoma, T Cell, Cutaneous) 01/15/2009 - "In addition, these peptides are involved in CD8+ T cell response to HIV-1, increased pulmonary infection risk among cystic fibrosis patients, upregulated levels of HNP-5 for patients with ulcerative colitis and Crohn's disease, and monitoring HNP-3 levels as a tumor classification scheme for cutaneous T cell lymphomas, and have promise in the pharmaceutical field as a new class of antibiotics. "
3.	Neoplasms (Cancer) 01/15/2009 - "In addition, these peptides are involved in CD8+ T cell response to HIV-1, increased pulmonary infection risk among cystic fibrosis patients, upregulated levels of HNP-5 for patients with ulcerative colitis and Crohn's disease, and monitoring HNP-3 levels as a tumor classification scheme for cutaneous T cell lymphomas, and have promise in the pharmaceutical field as a new class of antibiotics. "
4.	Infections 01/15/2009 - "In addition, these peptides are involved in CD8+ T cell response to HIV-1, increased pulmonary infection risk among cystic fibrosis patients, upregulated levels of HNP-5 for patients with ulcerative colitis and Crohn's disease, and monitoring HNP-3 levels as a tumor classification scheme for cutaneous T cell lymphomas, and have promise in the pharmaceutical field as a new class of antibiotics. "
5.	Cystic Fibrosis (Mucoviscidosis) 01/15/2009 - "In addition, these peptides are involved in CD8+ T cell response to HIV-1, increased pulmonary infection risk among cystic fibrosis patients, upregulated levels of HNP-5 for patients with ulcerative colitis and Crohn's disease, and monitoring HNP-3 levels as a tumor classification scheme for cutaneous T cell lymphomas, and have promise in the pharmaceutical field as a new class of antibiotics. "

Related Drugs and Biologics

1.	Peptides (Polypeptides)
2.	Anti-Bacterial Agents (Antibiotics)
3.	neutrophil peptide 5
4.	human neutrophil peptide 2
5.	human neutrophil peptide 1
6.	Amino Acids
7.	Biomarkers (Surrogate Marker)